POS0017 Bispecific T Cell-Engaging Antibodies to Target TRBV9+ Autoreactive T Cells in Axial Spondyloarthritis
Stephanie Glavaris(Johns Hopkins University), Maximilian F. Konig(Johns Hopkins University), Shiyi Zhou(Johns Hopkins University), Suman Paul(Johns Hopkins University), Kenneth W. Kinzler(Johns Hopkins University), Drew M. Pardoll(Bloomberg (United States)), Tushar D. Nichakawade(Howard Hughes Medical Institute), Chetan Bettegowda(Johns Hopkins University), Bert Vogelstein(Johns Hopkins University), Jing Liu(Johns Hopkins University), Jian Ge(Shandong Provincial Hospital), N. Marco(Johns Hopkins University), Tolulope O. Awosika(Johns Hopkins University), Colin Gliech(Johns Hopkins University), K.K. Kaeo(Johns Hopkins University), Alexander Pearlman(Johns Hopkins University)
Cited by 0
Related Papers
Safety, Activity, and Immune Correlates of Anti–PD-1 Antibody in Cancer
|New England Journal of Medicine|2012|12.6k
PD-1 Blockade in Tumors with Mismatch-Repair Deficiency
|New England Journal of Medicine|2015|9.4k
Cancer Genome Landscapes
|Science|2013|8k
Safety and Activity of Anti–PD-L1 Antibody in Patients with Advanced Cancer
|New England Journal of Medicine|2012|8k